Notice Health and Human Services DepartmentFood and Drug Administration February 6, 2026

Determination of Regulatory Review Period for Purposes of Patent Extension; AURORA EV-ICD

The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for AURORA EV-ICD and is publishing this notice of that determination as required by law. FDA has made...

Want the full context? Use Regulator to track the source, deadlines, and weekly briefing.
Document type: Notice. Agency: Health and Human Services Department, Food and Drug Administration. Published: 2026-02-06.

Why this matters to food and beverage teams

This notice is worth screening if your team tracks health and human services department, food and drug administration activity that could affect ingredients, labeling, plant operations, imports, or compliance timing.

Federal Register items are often early signals. Even when they look procedural, they can affect comment windows, effective dates, or how suppliers and plants plan around upcoming changes.

View original source document

Need the operator impact, not just the source document?

Get a custom Regulator Weekly Action Brief with the deadlines, business impact, and next actions that matter to your facility or product line. Your first custom brief is free.